ATE508740T1 - Mittel zur verringerung von müdigkeit - Google Patents
Mittel zur verringerung von müdigkeitInfo
- Publication number
- ATE508740T1 ATE508740T1 AT07744852T AT07744852T ATE508740T1 AT E508740 T1 ATE508740 T1 AT E508740T1 AT 07744852 T AT07744852 T AT 07744852T AT 07744852 T AT07744852 T AT 07744852T AT E508740 T1 ATE508740 T1 AT E508740T1
- Authority
- AT
- Austria
- Prior art keywords
- fatigue
- agents
- reducing fatigue
- salt
- reducing agent
- Prior art date
Links
- 239000003638 chemical reducing agent Substances 0.000 abstract 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 108010024636 Glutathione Proteins 0.000 abstract 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 229960003180 glutathione Drugs 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006158156 | 2006-06-07 | ||
PCT/JP2007/061522 WO2007142286A1 (ja) | 2006-06-07 | 2007-06-07 | 疲労軽減剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE508740T1 true ATE508740T1 (de) | 2011-05-15 |
Family
ID=38801532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07744852T ATE508740T1 (de) | 2006-06-07 | 2007-06-07 | Mittel zur verringerung von müdigkeit |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100137226A1 (de) |
EP (1) | EP2050444B1 (de) |
JP (1) | JP5085541B2 (de) |
CN (1) | CN101460159B (de) |
AT (1) | ATE508740T1 (de) |
WO (1) | WO2007142286A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2716780A1 (en) * | 2008-02-25 | 2009-09-03 | National University Corporation Hokkaido University | Prophylactic or therapeutic agent for diabetes or obesity |
CN102552457A (zh) * | 2010-12-24 | 2012-07-11 | 漆又毛 | 一种氨基酸和提取物组合物的药物用途 |
JP5997425B2 (ja) * | 2011-08-18 | 2016-09-28 | 協和発酵バイオ株式会社 | オルニチン含有組成物 |
CN102526750A (zh) * | 2012-01-06 | 2012-07-04 | 安徽黄山胶囊股份有限公司 | 一种植物结肠溶空心胶囊 |
WO2014051168A1 (en) * | 2012-09-28 | 2014-04-03 | Kyowa Hakko Bio Co., Ltd. | Agent for enhancing immunity containing glutathione |
JP2014159381A (ja) * | 2013-02-19 | 2014-09-04 | Kyowa Hakko Bio Co Ltd | オルニチン含有体組成改善用組成物 |
JP6646369B2 (ja) * | 2015-06-25 | 2020-02-14 | 株式会社東洋新薬 | 抗疲労剤 |
WO2017004396A1 (en) * | 2015-06-30 | 2017-01-05 | Nucorplabs, Inc. | Chewable composition to deliver gsh |
JP6469283B2 (ja) * | 2017-06-07 | 2019-02-13 | 花王株式会社 | アンモニア代謝促進剤 |
JP6829487B2 (ja) * | 2019-07-11 | 2021-02-10 | 株式会社東洋新薬 | 抗疲労剤 |
JP2021020881A (ja) * | 2019-07-30 | 2021-02-18 | 三菱商事ライフサイエンス株式会社 | 疲労回復剤 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1110392A (en) * | 1964-09-28 | 1968-04-18 | Yamanouchi Pharma Co Ltd | Composition containing glutathione and an amino acid or amino acids, and salts thereof |
US3428025A (en) * | 1966-12-27 | 1969-02-18 | Xerox Corp | Xerographic development apparatus |
ZA716628B (en) * | 1970-10-15 | 1972-06-28 | Richardson Merrell Spa | Composition and method for treatment of hepatic disease and mental fatigue |
JPS5324096A (en) | 1976-08-19 | 1978-03-06 | Kyowa Hakko Kogyo Co Ltd | Preparation of l-ornithine by fermentation |
JPS6174595A (ja) | 1984-09-21 | 1986-04-16 | Kyowa Hakko Kogyo Co Ltd | 物質の製造方法 |
JPS61119194A (ja) | 1984-11-15 | 1986-06-06 | Kyowa Hakko Kogyo Co Ltd | 発酵法によるl−オルニチンの製造法 |
DE69323731T2 (de) * | 1992-11-10 | 1999-07-22 | Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo | Futterzusammensetzung |
JPH08275752A (ja) * | 1995-04-07 | 1996-10-22 | Riken Vitamin Co Ltd | ストレス改善食品 |
JP2002338473A (ja) * | 2001-05-15 | 2002-11-27 | Yaizu Suisankagaku Industry Co Ltd | 抗疲労組成物 |
US6855727B2 (en) * | 2000-12-04 | 2005-02-15 | Yaizu Suisankagaku Industry Co., Ltd. | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
US7709460B2 (en) * | 2001-04-25 | 2010-05-04 | Cobalz Limited | Method for treating or preventing a functional vitamin B12 deficiency in an individual and medical compositions for use in said method |
DE10158498A1 (de) * | 2001-11-29 | 2003-07-24 | Becker Grubmueller Anuschka | Nahrungsergänzungspräparat |
US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
AU2004211978A1 (en) * | 2003-02-10 | 2004-08-26 | Todd Ovokaitys | Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form |
WO2004078171A1 (ja) * | 2003-03-06 | 2004-09-16 | Kyowa Hakko Kogyo Co., Ltd. | 吸水性アミノ酸含有錠剤 |
WO2007040244A1 (ja) * | 2005-10-04 | 2007-04-12 | Kyowa Hakko Kogyo Co., Ltd. | 疲労自覚症状改善用組成物 |
-
2007
- 2007-06-07 AT AT07744852T patent/ATE508740T1/de not_active IP Right Cessation
- 2007-06-07 US US12/303,613 patent/US20100137226A1/en not_active Abandoned
- 2007-06-07 JP JP2008520613A patent/JP5085541B2/ja active Active
- 2007-06-07 EP EP07744852A patent/EP2050444B1/de active Active
- 2007-06-07 WO PCT/JP2007/061522 patent/WO2007142286A1/ja active Application Filing
- 2007-06-07 CN CN2007800210370A patent/CN101460159B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
EP2050444A1 (de) | 2009-04-22 |
EP2050444B1 (de) | 2011-05-11 |
JP5085541B2 (ja) | 2012-11-28 |
CN101460159B (zh) | 2011-11-23 |
US20100137226A1 (en) | 2010-06-03 |
WO2007142286A1 (ja) | 2007-12-13 |
EP2050444A4 (de) | 2009-06-03 |
CN101460159A (zh) | 2009-06-17 |
JPWO2007142286A1 (ja) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE508740T1 (de) | Mittel zur verringerung von müdigkeit | |
WO2011061330A3 (de) | Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe | |
ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
UA101309C2 (ru) | Антагонисты активина-actrii и их применение для повышения уровня эритроцитов | |
ZA200902632B (en) | Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide | |
WO2007109330A3 (en) | S1p receptor modulating compounds | |
WO2012162331A3 (en) | Compositions comprising an efficient perfume bloom | |
MY145721A (en) | Non-irritating compositions containing zinc salts | |
BR112012027055A2 (pt) | agente estabilizante para proteínas farmacêuticas. | |
MX348797B (es) | Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel. | |
BRPI0810958A2 (pt) | "composição, método de controle curativo ou preventivo de fungos fitopatogênicos de safras e uso da composição" | |
EA200801164A2 (ru) | Ингибиторы протеина, активирующего 5-липоксигеназу (flap) | |
MY147247A (en) | Organic compounds and their uses | |
MX2007010560A (es) | Roflumilast para el tratamiento de diabetes mellitus. | |
ATE537828T1 (de) | Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin | |
WO2008149802A1 (ja) | アンドログラホリドを有効成分とする抗疲労剤及び経口組成物 | |
EA201100297A1 (ru) | Биотесты на белок polyq | |
WO2006128041A3 (en) | Compositions and methods for the treatment or prevention of chemoresistant neoplasia | |
WO2008105088A1 (ja) | 脊髄損傷治療薬剤 | |
MX2007011264A (es) | Composiciones nutricionales para modular la biodisponibilidad de vitamina c. | |
WO2006103660A3 (en) | Wearable soothing system | |
BR112014012966A2 (pt) | método para o controle da proliferação de pseudomonas; e uso de um agente de desinfecção | |
WO2007057436A3 (en) | Interferon in influenza | |
WO2008120263A3 (en) | Prokineticins receptors antagonists, derivatives and uses thereof | |
FR2907682B1 (fr) | Composition cosmetique et/ou pharmaceutique comprenant comme principe actif au moins un peptide et utilisation de ce peptide. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |